The present disclosure relates to a transportable device for providing a cooled, oxygen-containing gas flow for supplying to a body of mammal via the respiratory tract, in particular a human being, in order to lower the body temperature. The device comprises a storage device comprising at least one fluid reservoir and at least one heat exchanger, wherein the storage device is designed to store an oxygen-containing fluid in the fluid reservoir and for providing a discharge flow of the oxygen-containing fluid. The heat exchanger is designed to cool the provided discharge flow by transferring heat to a cooling stream of a stored fluid and provided by the storage device, and a cooled, oxygen-containing gas flow for supplying to the body emerges from the heat exchanger.

A cartridge assembly for an aerosol-generating system is provided, including a cartridge having upstream and downstream ends, a first compartment having a first air inlet and a first air outlet, and a second compartment having a second air inlet and a second air outlet; a cartridge holder, a portion of the cartridge being received within the cartridge holder; a mouthpiece having upstream and downstream ends, at least a portion of the cartridge holder is received within the mouthpiece, the downstream end of the cartridge is spaced apart from the downstream end of the mouthpiece and defines a mixing chamber therebetween, and another portion of the cartridge holder is spaced apart from the mouthpiece and defines an airflow channel between the cartridge holder and the mouthpiece; and a ventilation air aperture providing fluid communication between a downstream portion of the airflow channel and the mixing chamber.

A drug delivery device includes a housing, a drug delivery assembly disposed within the housing along a longitudinal axis, and a cap defining a shell. At least one electronic component, a power source, and a switch assembly are at least partially disposed in and coupled to the cap. The switch assembly is movable along a plane orthogonal to the longitudinal axis of the drug delivery assembly to cause the power source to provide power to the electronic component. The device further includes an activation mechanism at least partially disposed in the cap. Upon urging the cap along the longitudinal axis in a direction away from the housing, the activation mechanism engages the switch assembly and causes the switch assembly to move, thereby causing the power source to provide power to the at least one electronic component.

Some embodiments have a pump assembly mounted to or supported by a dressing for reduced pressure wound therapy. The dressing can have visual pressure, saturation, and/or temperature sensors to provide a visual indication of the level of pressure, saturation, and/or temperature within the dressing. Additionally, the pump assembly can have a pressure sensor in communication with the flow pathway through the pump, and at least one switch or button supported by the housing, the at least one switch or button being accessible to a user and being in communication with the controller. The pump assembly can have a controller supported within or by the housing, the controller being configured to control an operation of the pump. The pump can be configured to be sterilized following the assembly of the pump such that all of the components of the pump have been sterilized.

A pharmaceutical product including a housing that defines a cavity, wherein the cavity stores a pharmaceutical material, and wherein the housing comprises a material configured to dissolve based on contact with a fluid, an ingestible device to encode information in a current signature, wherein the ingestible device is positioned within the housing, and a protective material that encompasses the ingestible device. The ingestible device may be attached to a flexible component, wherein the flexible component is configured to releasably secure the ingestible device within the housing.

Embodiments disclosed herein include devices for time release of measured quantities of an active ingredient and storage of animal management information. One embodiment disclosed herein releases an active ingredient, which is useful in the ruminant art, within the rumen and, then, at optionally varied intervals, releases additional doses into the same environment. The active ingredients are compartmentalized and, upon receiving an appropriate signal, use a magnetic field to expel the active ingredient into the rumen of the animal. The doses of active ingredient may be delivered simultaneously, sequentially, or independently. Further, the doses of active ingredient may be the same active ingredient or different active ingredients, in any formulation. Another embodiment described herein stores animal management information, such as identification or dosage information, and wirelessly communicates the stored information to an external device.

Various methods and apparatus disclosed herein relate to apparatus and techniques for harvesting energy from operation of a syringe, and utilizing that energy for various purposes. In various embodiments, a method (400) for harvesting and using electrical energy during operation of a syringe (100, 300) may include: operating (402) the syringe, wherein operating includes displacing a plunger (112) of the syringe to draw fluid into a reservoir (114) of the syringe or expel fluid from the reservoir of the syringe; converting (404), by an electrical generator (120, 122) that is integral with the syringe, motion associated with displacing the plunger into electrical energy; and using (406) at least some of the electrical energy to at least temporarily store, in a memory component (136) integral with the syringe, one or more data points associated with operation of the syringe.

The present invention discloses a liquid medicine injection device that is attached to a patient's body to inject liquid medicine such as insulin at an appropriate time.

A liquid medicine injection device according to the present invention includes: a case; a liquid medicine tank that is disposed in the case and where liquid medicine is received; an electro-osmosis pump that is connected with the liquid medicine tank and moves the liquid medicine; a needle assembly that receives the liquid medicine by being connected to the electro-osmosis pump and injects the received liquid medicine into a human body; and an adhesive member combined to the case and attached to the human body.

An ultrasonic topical applicator and method is provided for dispensing a topical including an adjustable head including a mesh nebulizer having a perforated plate with a plurality of pores and a vibrating actuator, a cartridge having a reservoir for holding a topical and a port configured to secure the reservoir to the mesh nebulizer, and a handle including a power source and a controller configured to control energy from the power source to the mesh nebulizer based on an energy profile, where the vibrating actuator is configured to produce ultrasonic vibration based on the energy profile, and where the adjustable head is configured to lock into within the handle and to allow the adjustable head to rotate.

An active molecule delivery system whereby active molecules can be released on demand and/or a variety of different active molecules can be delivered from the same system and/or different concentrations of active molecules can be delivered from the same system. The invention is well-suited for delivering pharmaceuticals to patients transdermally. In some embodiments, the system includes two separate reservoirs and a mixing area thereby allowing precursors to be mixed immediately before transdermal delivery.